Podcasts about drugs

EVEN MORE about this episode!What if your aura already reveals your soul's greatest gifts—and the lessons you're here to learn?In this episode of the Ask Julie Ryan Show, Julie Ryan welcomes Hay House author Helen Ye Plehn to explore how aura colors can reveal your soul purpose, hidden strengths, and spiritual path.Helen explains the difference between mood, personality, and soul auras, revealing why your soul aura represents the deepest energetic blueprint you've carried across lifetimes. Using Julie as a live example, she demonstrates how aura colors can uncover healing gifts, natural talents, and the unique qualities your soul came here to express.Together they explore the nine soul archetypes, Kundalini awakening, meditation, rainbow auras, star beings, the Aquarian Age, and how seemingly different spiritual traditions often point to the same universal truths. Whether you're curious about your aura, searching for your life purpose, or looking to better understand your spiritual gifts, this episode offers practical insights and a fresh perspective on who you truly are beneath the surface.Guest Biography:Helen Ye Plehn is the founder of Helen Creates Beauty and the award-winning author of The Aura Color Wheel, published by Hay House. She created the Aura Color Wheel™, a soul discovery system that helps people identify their life purpose through their Soul Aura Color.Helen is an intuitive painter, angel channeler, certified crystal healer, third-generation Feng Shui master, and Flamenco dancer. She is also the host of the Aura Evolution Podcast.Her mission is to help one million souls discover and live their purpose with joy and fulfillment.

Ben Gleib joins Ralph Sutton and Aaron Berg and they discuss knowing he wanted to be a comedian since he was a child, getting into the industry, dealing with having a studio in his apartment, starting his talk show, a new game Unborn Identity where after Ben's viral moment with Charlie Kirk they try to identify the animal fetuses, Ben Gleib's first concert, first drug and first sexual experience and so much more! Air Date: 07/25/26To advertise your product or service on GaS Digital podcasts please go to TheADSide.com and click on "Advertisers" for more information!You can watch The SDR Show LIVE for FREE every Wednesday and Saturday at 9pm ET at GaSDigitalNetwork.com/LIVEOnce you're there you can sign up at GaSDigitalNetwork.com with promo code: SDR for discount on your subscription which will give you access to every SDR show ever recorded! On top of that you'll also have the same access to ALL the shows that GaS Digital Network has to offer!Follow the whole show on social media!Ben GleibInstagram: https://instagram.com/BenGleibGood Night With Ben Gleib: https://www.youtube.com/@goodnightAaron BergTwitter: https://twitter.com/aaronbergcomedyInstagram: https://instagram.com/aaronbergcomedyRalph SuttonTwitter: https://twitter.com/iamralphsuttonInstagram: https://www.instagram.com/iamralphsutton/Shannon LeeTwitter: https://twitter.com/IMShannonLeeInstagram: https://instagram.com/ShannonLee6982The SDR ShowTwitter: https://twitter.com/theSDRshowSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

From 2025 My website My Instagram

DISCLAIMER: This video is a historical documentary about medicine, pharmacy, and substance use in 19th-century America. It is intended for educational and informational purposes only. Nothing in this video promotes, encourages, or provides instruction for the use of any illegal substance. Many of the substances discussed were legal during the period covered but are now controlled substances. They caused enormous harm, addiction, and loss of life, both then and now. This channel does not condone or promote illegal drug use of any kind. If you or someone you know is struggling with substance abuse, help is available through the SAMHSA National Helpline at 1-800-662-4357, a free, confidential, 24/7 resource.   This is a documentary-style look at pharmaceutical use on the American frontier. We cover the history of morphine and the hypodermic syringe, the myth of the Civil War Soldier's Disease, the real history of opium dens in mining towns like Virginia City, the first anti-opium laws in American history, and the truth behind certain movies like Tombstone and Wild Bill. We also dig into the history of cocaine in patent medicine, whether cowboys really smoked cannabis, Quanah Parker and his advocacy of peyote, Doc Holliday's use of laudanum, and how Bayer marketed heroin as a cough remedy in 1898.   Wild West Quiz - https://wildwestquiz.com/   Check out the website! https://www.wildwestextra.com/   Email me! https://www.wildwestextra.com/contact/   Free Newsletter! https://wildwestjosh.substack.com/   Buy Me A Coffee!  https://buymeacoffee.com/wildwest   Join Patreon for ad-free bonus content! https://www.patreon.com/wildwestextra   Merch! https://wildwestextramerch.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Psychedelics, hallucinogens, natural medicines, you name it, we're covering it on this episode of the Pain Pod folks! We'll chat through all types of psychedelics including LSD, MDMA, Psilocybin, DMT, and Ketamine and beyond. No trippin' just learnin'! You're not going to want to miss this one! Come one, come all, to the Pain Pod!!! Pain Guy www.painguy.us

Psychedelics, hallucinogens, natural medicines, you name it, we're covering it on this episode of the Pain Pod folks! We'll chat through all types of psychedelics including LSD, MDMA, Psilocybin, DMT, and Ketamine and beyond. No trippin' just learnin'! You're not going to want to miss this one! Come one, come all, to the Pain Pod!!! Pain Guy www.painguy.us

Tara Perry grew up in Texas with her father out of the picture, raised by her mother and grandparents in a family where functioning addiction was just part of daily life — which is how she first got exposed to meth as a teenager and started using at just 13 years old. In this episode of Locked In with Ian Bick, she shares how she dropped out of school in ninth grade, had her first child at 16, spent six months in state prison before a five year sentence in the Texas Department of Corrections before she was even 20 years old, and stayed hooked on meth from age 13 all the way to 26 — always managing to get sober inside jail or prison before the cycle started again on the outside. She opens up about eventually starting to sell meth, getting connected to a major organization, having multiple children while in and out of addiction, and what happened when someone close to her snitched and the DEA came knocking. She was sentenced to 20 years in federal prison — and spent seven of those years inside a Texas federal facility before Donald Trump pardoned her on the last day of his first term.  _____________________________________________ #prison #addictionrecovery #truecrimecommunity  _____________________________________________ Connect with Tara Perry: https://www.instagram.com/princesstara.3313/  _____________________________________________ Hosted, Executive Produced & Edited By Ian Bick: https://www.instagram.com/ian_bick/?hl=en https://ianbick.com/ _____________________________________________ Timestamps: 00:00 Introduction and Early Life 03:50 Childhood, Family & Identity 09:50 First Exposure to Drugs 16:00 Teenage Drug Use & Relationships 23:00 First Criminal Charges & Jail Experience 31:30 Life After First Incarceration 39:00 Motherhood and Continued Addiction 47:00 Second Prison Sentence & Having a Baby in Jail 55:30 Release, Relapse, and Escalating Drug Trade 01:03:30 DEA Bust and Facing Federal Charges 01:10:00 Sentencing and Time in Federal Prison 01:18:00 Life, Change, and Purpose in Prison 01:29:00 Clemency and Life After Prison 01:36:00 Growth, Healing, and Closing Reflections  _____________________________________________ To advertise on the show, contact sales@advertisecast.com or visit https://advertising.libsyn.com/LockedInWithIanBicka

Is being too hot a discriminatory class? How many engagements are too many? How do you mix drugs and sex? Comedian Anne Flagg tackles all of these topics and more on the latest Manwhore Podcast! PLUS! Some sexy movie suggestions for your next trip to the theater. Mentioned:PHILADELPHIA - 8/1 - https://www.eventbrite.com/e/1992372794662NYC - 8/20 - https://www.eventbrite.com/e/1995206338869CHI - 9/19 - https://www.eventbrite.com/e/1994964794403Movies mentioned: I Want Your Sex, The Invite, Touch Me, Paying for It, Pillion Follow Anne Flagg!Instagram: @in_anneticipationwww.AnneFlaggsMouth.com Follow Billy!Instagram: @billyprocidajrTikTok: @TheBillyProcidaThreads: @billyprocidajrBlueSky: @thebillyprocida Money StuffVenmo: @BillyProcidaCash App: $billyprocidaPayPal/Zelle: funnybillypro@gmail.com Become a member and join The Peep Show at http://patreon.com/manwhorepodcast Get your books and e-books through an independent bookstore at http://manwhorepod.com/bookshop Just be chill in The Champagne Room at http://manwhorepod.com/discord Email your comments, questions, and criticisms to manwhorepod@gmail.com. Late Night Radio and Joey's Formal Waltz by Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 3.0 Licensehttp://creativecommons.org/licenses/by/3.0/ www.ManwhorePod.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Send Zorba a message!Zorba examines new research that suggests early social media use in tweens can lead to substance experimentation. He helps a caller with questions about her cholesterol, and helps folks with prostate health and creatine questions. And Zorba gets a smack down from the Grammar Cops about sex and cell phone use.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!

Natalie King joins Ralph Sutton and Aaron Berg and they discuss Natalie's love of latex, how she got into the adult industry, the BDSM experience, her most frequent dom requests, making friends with clients, Ralph's crazy date story, a game of Punish the Beta where Ralph and Aaron compete to see which is the more alpha guy and after each round Natalie punishes the beta, we also find out Natalie's first concert, first drug and first sexual experience and so much more!Air Date: 07/22/26Support our sponsors!YoKratom.com - Check out Yo Kratom (the home of the $60 kilo) for all your kratom needs!To advertise your product or service on GaS Digital podcasts please go to TheADSide.com and click on "Advertisers" for more information!You can watch The SDR Show LIVE for FREE every Wednesday and Saturday at 9pm ET at GaSDigitalNetwork.com/LIVEOnce you're there you can sign up at GaSDigitalNetwork.com with promo code: SDR for discount on your subscription which will give you access to every SDR show ever recorded! On top of that you'll also have the same access to ALL the shows that GaS Digital Network has to offer!Follow the whole show on social media!Natalie KingInstagram: https://instagram.com/natalie.king.nycAaron BergTwitter: https://twitter.com/aaronbergcomedyInstagram: https://instagram.com/aaronbergcomedyRalph SuttonTwitter: https://twitter.com/iamralphsuttonInstagram: https://www.instagram.com/iamralphsutton/Shannon LeeTwitter: https://twitter.com/IMShannonLeeInstagram: https://instagram.com/ShannonLee6982The SDR ShowTwitter: https://twitter.com/theSDRshowSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kojo Koram joins This Is Hell! to talk about his new book "The Next Fix: The Winners and Losers in the Future of Drugs”, published by Verso Books. (https://www.versobooks.com/products/3173-the-next-fix)

 Kojo Karma is a Professor in Law and Political Economy at the School of Law at Loughborough University. He is the author of, "Uncommon Wealth: Britain and the Aftermath of Empire”, published by John Murray Press. In addition to his academic writing, he has written for the New Statesman, the Guardian and the New York Times.

Follow Kojo on Instagram at @kojokoram and on X @kojokoram. We will have new installments of Rotten History and Hangover Cure. We will also be sharing your answers to this week's Question from Hell! from Patreon. Help keep This Is Hell! completely listener supported and access bonus episodes by subscribing to our Patreon: www.patreon.com/thisishell

My website My Instagram

For more than five decades, Nicholas Freudenberg has been at the forefront of some of the most consequential public health movements in America. As Distinguished Professor Emeritus of Public Health at the City University of New York (CUNY), he has dedicated his career to understanding—and transforming—the social, political, and economic forces that shape health outcomes. In this compelling episode of Let's Have This Conversation, Nicholas shares why improving public health requires far more than advances in medicine. It demands courageous leadership, community activism, policy reform, and a willingness to challenge systems that perpetuate inequality. Our conversation explores the evolution of public health activism through the lens of some of society's most pressing challenges, including: Nicholas also discusses his newest book, Fighting for New York: Activism for Health and Social Justice Since the 1960s, which chronicles decades of grassroots organizing and reveals the lessons today's leaders, advocates, educators, and policymakers can apply to create healthier, more equitable communities. As the founder of CUNY's Urban Food Policy Institute, the Hunter College Center on AIDS, Drugs and Community Health, and the university-wide Healthy CUNY initiative, Nicholas has spent a lifetime turning research into action. His work demonstrates that meaningful societal change happens when academic knowledge, community engagement, and public policy come together. Whether you're a public health professional, healthcare leader, policymaker, nonprofit executive, educator, student, or simply someone passionate about creating healthier communities, this conversation offers valuable insights into how collective action can improve lives and shape a more just society. This episode examines critical questions facing communities around the world: Join us for an insightful conversation about leadership, advocacy, public policy, social justice, and the enduring power of ordinary people working together to create extraordinary change.   For more Information: https://sph.cuny.edu/about/people/faculty/nicholas-freudenberg/ Get the Book: https://cup.columbia.edu/book/fighting-for-new-york/9780231221405/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Adi Jaffe is a UCLA-trained psychologist, nationally recognized addiction expert, and bestselling author of The Abstinence Myth and Unhooked. Drawing from both his clinical expertise and his personal experience overcoming addiction and incarceration, he challenges traditional, shame-based recovery models and helps people address the emotional patterns driving destructive behaviors. Today on the show we discuss why addiction is often a solution to deeper emotional pain rather than the problem itself, how trauma and social anxiety can drive compulsive substance use, why removing the substance without addressing the underlying pattern can lead to relapse or replacement behaviors, how changing your internal narrative can reduce the need to escape, the daily practices that rebuild confidence and emotional stability over time, and why setbacks can become lessons that accelerate lasting change and much more. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dave Crosland and Scott McNally are back to answer your bodybuilding and PED questions! This week, two listener questions have us breaking down advice from Dave Palumbo. Do we agree with his recommended off-season cycle? What about his thoughts on using trenbolone year-round? We explain where we disagree, where we think his recommendations come from, and why context is everything when it comes to PED use. Plus we discuss the new peptide KW-6356, why two training partners can have very different blood work, whether TRT changes the effects of recreational drugs, estrogen management, whether 10-week cycles are long enough to build muscle, and much more. As always, this podcast is for educational and entertainment purposes only and is intended for mature audiences. ⏱️ TIMESTAMPS 0:00 Tren Replacement Therapy 0:25 Support our Advertisers to support the show 2:45 Calling Out Dave Palumbo 6:30 Critiquing Dave Palumbo's Off-Season Cycle 18:15 Dave Palumbo's Take on Year-Round Tren 32:45 KW6356 – A Refined Stimulant? 46:20 Why Two Training Partners Can Have Very Different Lab Results 51:30 Dave's Health Issues – Gear or Body Fat? 53:00 Does TRT Make Recreational Drugs Less Effective? 56:15 Estrogen Build-Up on TRT 1:00:10 Do 10-Week Cycles Actually Work? 1:06:00 Uncle Dave's Wisdom UK Blood Work Get your Labs done by Dave in the UK : https://evalbloodanalysis.com/home/ Support the Podcast Patreon — Help keep the show growing. Even $5/month makes a difference. https://www.patreon.com/thinkbigbodybuilding Sponsors TRUE NUTRITION — Custom supplements for serious lifters Use code THINK to save https://www.truenutrition.com/THINK STROM SPORTS — Performance supplements trusted by athletes UK: https://tinyurl.com/ydmbfa54 US: https://stromsportsus.com Supplement Source Canada — Top brand supplements with fast shipping http://www.supplementsource.ca Merch Official THINK BIG Merch — Train, represent, support the brand https://think-big.printify.me/products

Hour 2 for 7/27/26 Drew and Helen pray the Chaplet of Divine Mercy (1:00). Then, Dr. Anthony Jay covers the abortion drugs found in tap water (27:26). Finally, Mary Rice Hansson covers transgender dolls in the classroom (40:54) and why this is dangerous for kids (40:54). Links: https://waltheyer.com/ https://a.co/0ewgszhf https://issuesinlawandmedicine.com/articles/anti-progesterone-in-environmental-water/ https://eppc.org/author/mary_hasson/ https://personandidentity.com/

The post The PASI Paradigm Shift: How Higher Clinical Trial Endpoints Are Reshaping Dermatology appeared first on JDDonline - Journal of Drugs in Dermatology.

The 2026 World Cup has finished and the final two teams, Spain and Argentina, have stirred up old notions of what we call soft power. Sports play a large role in how countries display their soft power, but it can often be confused for cooperation. Indeed all power is contested and soft power is no exception, and the contest is clear when two national teams meet in a sports contest. Examples of soft power interactions in sports include the US beating the USSR in hockey in the 1980 Winter Games or the Soviets defeating the US in basketball at the 1972 Olympics during the height of the Cold War. No sport, however, garners more international interest than soccer (or what the rest of the world calls football). Our guests have written a new book that defines the Cold War rivalry through the lens of ten historic soccer matches. The book is called Cold War Football: A history in Ten matches. [ dur: 33mins. ] Tony Shaw is Professor of Contemporary History at the University of Hertfordshire. He is the co-author of The American and Soviet Struggle for Hearts and Minds and Hollywood and Israel: a History. Alan McDougall is Professor of History at the University of Guelph. He is the author of Contested Fields; A Global History of Modern Football and Dreams and Songs to Sing: A People's History of Liverpool FC from Shankly to Klopp. We revisit the September 11th, 1973 coup in Chile that toppled democratically elected Salvador Allende and installed the dictator Augustin Pinochet. We'll hear what happened, explore the latest revelations and how Chileans are dealing with their past now.  [ dur: 25mins. ] For a transcript of this interview, please visit: TheBigQ This interview was recorded September, 2014. John Dingus is Professor of Journalism at Columbia University. He is the author of The Condor Years: How Pinochet And His Allies Brought Terrorism To Three Continents and Our Man in Panama: How General Noriega Used the United States- And Made Millions in Drugs and Arms Peter Kornbluh directs the Cuba Documentation Project and the Chile Documentation Project at the National Security Archives. He is the author of The Pinochet File: A Declassified Dossier on Atrocity and Accountability, co-author of Back Channel to Cuba: The Hidden History of Negotiations between Washington and Havana and  The Iran-Contra Scandal: The Declassified History. This program is produced by Ankine Aghassian, Doug Becker, Sudd Dongre, and Anna Lapin. Politics and Activism, Diplomacy, Social Sciences, Organized Sports

My website My Instagram

Saagar Shaikh joins Ralph Sutton and Aaron Berg and they discuss Deli Boys and Abdullah Saeed being on a former episode of The SDR Show, Saagar's family coming from Pakistan, deciding to move to LA despite his father's doubt, starting a beard oil business, googling How To Become An Actor, getting a role on Ms. Marvel, the unlikely events that got him his role on Deli Boys, a game of Deli Meat Trivia, Saagar's first concert, first drug and first sexual experience and so much more!Air Date: 07/18/26To advertise your product or service on GaS Digital podcasts please go to TheADSide.com and click on "Advertisers" for more information!You can watch The SDR Show LIVE for FREE every Wednesday and Saturday at 9pm ET at GaSDigitalNetwork.com/LIVEOnce you're there you can sign up at GaSDigitalNetwork.com with promo code: SDR for discount on your subscription which will give you access to every SDR show ever recorded! On top of that you'll also have the same access to ALL the shows that GaS Digital Network has to offer!Follow the whole show on social media!Saagar ShaikhInstagram: https://instagram.com/SaagarShaikhAaron BergTwitter: https://twitter.com/aaronbergcomedyInstagram: https://instagram.com/aaronbergcomedyRalph SuttonTwitter: https://twitter.com/iamralphsuttonInstagram: https://www.instagram.com/iamralphsutton/Shannon LeeTwitter: https://twitter.com/IMShannonLeeInstagram: https://instagram.com/ShannonLee6982The SDR ShowTwitter: https://twitter.com/theSDRshowSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week on This Week in AML, Elliot Berman and Joe McNamara examine a series of reports and regulatory updates highlighting the growing sophistication of global financial crime. The discussion begins with a new United Nations Office on Drugs and Crime (UNODC) threat assessment that details how Southeast Asia has become a hub for interconnected criminal ecosystems, with organized crime groups increasingly offering “fraud as a service” at enterprise scale. Elliot and Joe explore how criminal organizations are evolving from trafficking goods to operating highly sophisticated criminal services businesses. They also discuss FATF's latest targeted update on virtual assets and VASPs, including concerns about stablecoins, regulatory gaps, and ongoing challenges in implementing the Travel Rule across jurisdictions. The conversation highlights how organized crime networks are leveraging crypto assets to move illicit funds globally. The episode then turns to new guidance from the Wolfsberg Group on managing risks associated with non-bank payment service providers, AMLA's growing focus on vulnerabilities in the non-financial sector, and ongoing concerns about real estate as a money-laundering vehicle.

Legendary singer Graham Nash still on tour:  ☮️ 56 years ago this summer was Woodstock, only their second show ever as CSNY ❤️ Living with Joni during their first show ✨ Did he realize he was changing music forever

Southwest Michigan's Morning News podcast is prepared and delivered by the WSJM Newsroom. For these stories and more, visit https://www.wsjm.com and follow us for updates on Facebook. See omnystudio.com/listener for privacy information.

A new report is warning that festival drugs in Ireland could contain dangerous synthetic opioids known as nitazenes. They can be hundreds of times stronger than heroin and linked to fatal overdoses To discuss the risks was Nicki Killeen, Project Manager for Emerging Drug Trends with the HSE.

Michael Nader is a behavioral neuropharmacologist with research interest in the areas of drug abuse, impulsivity, brain dopamine receptor function and nonhuman primate models of human disease. He has been working with catheterized nonhuman primate models for nearly 35 years and with brain imaging (PET and MRI) for over 25 years. His research examines individual differences in drug effects, highlighting sex differences, social rank and drug history as important organismal variables that influence outcome. Read more about Dr. Nader's work at https://school.wakehealth.edu/research/labs/michael-nader-lab

Come with Brandon down the rabbit hole and learn how the opioid crisis got so bad and who was at fault.

Professor Donal O'Shea, Specialist in Obesity, discusses new research exploring the link between hair loss and the use of weightloss drugs.

A former occult practitioner describes himself as a "walking motel for unclean spirits”. He tells of his experience of drug induced demonic encounters and how he eventually was lead to the Lord. It's an incredible story of how the Lord can save someone even in their deepest and darkest moments!New Haunted Cosmos shirt available for a limited time! - Get it here!Love Haunted Cosmos? Get access to our exclusive show, The Dusty Tome, early ad-free access to main episodes and monthly Livestreams, by becoming a patron of the show: https://www.patreon.com/c/HauntedCosmosThis episode is sponsored by: Indigo Sundries Soap Company - Go to http://indigosundriessoap.com and use code HAUNTEDCOSMOS for 10% off your whole order!Stonecrop Wealth Advisors! Go to this link to check out their special offers to Haunted Cosmos listeners today. https://stonecropadvisors.com/hauntedcosmosTalk to Josh at Volenté Creative to get help you with your branding and marketing: https://volentecreative.com/ncpGray Toad Tallow. Visit their website here and use COSMOS15 at checkout for 15% off your order. https://graytoadtallow.com/Buy the Haunted Cosmos book: https://www.newchristendompress.com/cosmos PS: It's also available as an audiobook!If you're a Christian business owner who wants to reach thousands of like-minded people and grow your company, we'd love to partner with you. Email us at advertising@NewChristendomPress.com Support the show

Episode 26-29 The 2 Causes Of ALL Disease It's hard for your body to heal from a disease if you don't eliminate the underlying cause. That's a pretty logical statement, right? It is. Unfortunately, it's not one that's adhered to… especially by the medical profession. Their strategy isn't to eliminate the CAUSE of disease. Its to prescribe drugs that will "treat" the corresponding symptoms. For example, a medical doctor will prescribe drugs for a man with high blood pressure. Drugs he must take for the rest of his life. Drugs that will NOT correct the underlying cause of his high blood pressure. Drugs that have negative side-effects. It doesn't make sense. It's also not different for any other chronic disease. The doctor will prescribe drugs. Drugs that will do nothing more than "manage" the symptoms. Drugs that will NOT correct the underlying cause. Drugs that will NOT promote healing. There has to be a better way. There IS a better way. An approach to health care that seeks to identify and correct the underlying CAUSE of chronic disease. On this week's episode I share with you the underlying cause of chronic disease. Specifically, I talk about the TWO causes that, in my opinion, are at the root of all chronic disease. This is an episode you DON'T want to miss as it holds the blueprint for healing. Give it a good listen and, as always, share it with a friend. Thanks!  ———————- Want to learn more? Continue the conversation regarding this episode, and all future episodes, by signing up for our daily emails. Simply visit: GetHealthyAlabama.com  Once there, download the "Symptom Survey" and you will automatically added to our email list. ———————- Also, if you haven't already, we'd appreciate it if you'd subscribe to the podcast, leave a comment and give us a rating. (Thanks!!!)  

               * This podcast is for informational and educational purposes only. It is not intended to diagnose or treat any disease. Please consult with your health care provider before making any health-related changes.

KMOX Legal Analyst Brad Young says lawsuits are already being filed against Taco Bell by individuals impacted by the cyclospora outbreak; Elijah Gantt heads to court for his role in the injury of a Ferguson police officer; and a new lawsuit in a weight-loss drug case.

Crazy share house stories, the different drugs including 2CE, Lebo weed dispensaries, how AI might use a human ass as a 5G router. Support the show by joining our Patreon: https://www.patreon.com/NeuroticNews

Brad Williams joins Ralph Sutton and Aaron Berg and we find out how hustling got Brad everything he wanted, why he's such a nice guy, his martial artist wife teaching their daughter to defend herself, using the "m" word, working with Carlos Mencia, getting thrown off the air, being a player before getting married, Brad Williams' first concert, first drug and first sexual experience and so much more! Air Date: 07/15/26Support our sponsors!YoKratom.com - Check out Yo Kratom (the home of the $60 kilo) for all your kratom needs!To advertise your product or service on GaS Digital podcasts please go to TheADSide.com and click on "Advertisers" for more information!You can watch The SDR Show LIVE for FREE every Wednesday and Saturday at 9pm ET at GaSDigitalNetwork.com/LIVEOnce you're there you can sign up at GaSDigitalNetwork.com with promo code: SDR for discount on your subscription which will give you access to every SDR show ever recorded! On top of that you'll also have the same access to ALL the shows that GaS Digital Network has to offer!Follow the whole show on social media!Brad WilliamsInstagram: https://instagram.com/bradwilliamscomicAaron BergTwitter: https://twitter.com/aaronbergcomedyInstagram: https://instagram.com/aaronbergcomedyRalph SuttonTwitter: https://twitter.com/iamralphsuttonInstagram: https://www.instagram.com/iamralphsutton/Shannon LeeTwitter: https://twitter.com/IMShannonLeeInstagram: https://instagram.com/ShannonLee6982The SDR ShowTwitter: https://twitter.com/theSDRshowSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

My website My Instagram

Looking at the history and coincidences behind the 27 Club, a tragic collection of famous celebrities who passed at that age, including Brian Jones, Jimi Hendrix, Kurt Cobain, and more.Support us directly: https://www.redwebpod.comWhen a young person skyrockets to fame, how they deal with the pressure can often make or break the rest of their life. Drugs and partying; the classic rockstar lifestyle is often the downfall of these young, up and coming stars. And as the 60s faded into the 70s, some started to notice an odd pattern; several of the most iconic musicians in the world, all died within a very short timespan. But the strangest part? They were all the exact same age. Today, we're investigating the history and theories behind the infamous 27 Club.Sensitive topics: Suicide, suicide attempts, drug overdose, drug addiction Learn more about your ad choices. Visit megaphone.fm/adchoices

A wrong turn at a university party plunged William "Gibby" Gibson into Jamaica's violent drug underworld, where mobsters, assassins, prison, and betrayal became everyday realities. In this unforgettable conversation, he recounts an astonishing true story of survival, miracles, and the faith that transformed a life destined for destruction GUEST: William "Gibby" Gibson is a Canadian author, businessman, and former international marijuana smuggler whose extraordinary life inspired Escape from Jamaica. After surviving Jamaica's brutal prison system, assassination attempts, and decades inside the criminal underworld, Gibson emerged with a powerful story of faith, redemption, and the unseen providence he believes saved his life. BOOKS: Escape From Jamaica: A True Story of Crime, Faith and Redemption FOLLOW RICHARD Website: https://www.strangeplanet.ca YouTube: @strangeplanetradio Instagram: @richardsyrettstrangeplanet TikTok: @therealstrangeplanet SUPPORT OUR SPONSORS!!! MARS MEN Mars Men helps you reclaim your edge with natural testosterone support for energy, focus, and strength Go to MenGoToMars.com right now, for a limited time, listeners of this program get 50% off for life, plus free shipping AND 3 free gifts. QUINCE Luxury, European linen that gets softer with every wash! Turn up the luxury when you turn in with Quince. Go to Quince dot com slash RSSP for free shipping on your order and 365-day returns. Now available in Canada, too. CARGURUS CarGurus is the #1 rated car shopping app in Canada on the Apple App and Google Play store. They've got hundreds of thousands of cars from top-rated dealers, plus advanced search tools that let you zero in on exactly what you want. And you can set real-time alerts for price drops and new listings — so you never miss a great deal. Buy your next car today with CarGurus at cargurus dot ca. Go to cargurus dot ca to make sure your big deal is the best deal. ⁠ BECOME A PREMIUM SUBSCRIBER!!!⁠ ⁠https://strangeplanet.supportingcast.fm⁠ Three monthly subscriptions to choose from. Commercial Free Listening, Bonus Episodes and a Subscription to my monthly newsletter, InnerSanctum. Visit ⁠https://strangeplanet.supportingcast.fm⁠ Use the discount code "Planet" to receive $5 OFF any subscription. We and our partners use cookies to personalize your experience, to show you ads based on your interests, and for measurement and analytics purposes. By using our website and services, you agree to our use of cookies as described in our Cookie Policy. Learn more about your ad choices. Visit ⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://strangeplanet.supportingcast.fm/

Why do steroids stop producing the same gains over time? In this episode of Drugs N Stuff, Scott McNally and Dave Crosland explain why simply running more drugs for longer eventually leads to diminishing returns—and how experienced bodybuilders structure long growth phases to keep making progress. Plus, we answer your questions on testosterone isocaproate, DHB, Dutasteride, Retatrutide, NAD+, P-21, sauna use, TRT injection frequency and much more. ⏱ TIMESTAMPS 0:00 Why Steroids Eventually Stop Working 1:00 Support Our Sponsors 3:45 How to Plan a 12-Month Growth Phase 13:40 Start Low, Build Slowly & Extend Your Cycle 20:30 Testosterone Isocaproate Half-Life Explained 24:10 Can You Re-Sensitize Yourself to Stimulants? 29:40 Scott's Experience with P-21 31:40 Selank: Scott's Honest Experience 32:50 Low-Dose Testosterone + DHB for a Specific Look 37:00 Sauna Benefits While Using PEDs 41:00 Can Retatrutide Reduce Addiction? 45:00 NAD+ Benefits & Can You Overdo Mitochondria? 48:45 Why Some Lifters Are Leaving Daily TRT Injections 49:45 Does Dutasteride Protect Against Dianabol Hair Loss? 51:50 Why Hydrochlorothiazide Is NOT Potassium Sparing 54:30 LSD as a Treatment for Depression 56:00 Uncle Dave's Wisdom 1:04:00 We Need to Buy Dave a Horn Check out all our affiliates at http://www.thinkbigbodybuilding.com UK Blood Work Get your Labs done by Dave in the UK : https://evalbloodanalysis.com/home/ Support the Podcast Patreon — Help keep the show growing. Even $5/month makes a difference. https://www.patreon.com/thinkbigbodybuilding Sponsors TRUE NUTRITION — Custom supplements for serious lifters Use code THINK to save https://www.truenutrition.com/THINK STROM SPORTS — Performance supplements trusted by athletes UK: https://tinyurl.com/ydmbfa54 US: https://stromsportsus.com Supplement Source Canada — Top brand supplements with fast shipping http://www.supplementsource.ca Merch Official THINK BIG Merch — Train, represent, support the brand https://think-big.printify.me/products

It may not seem like a big deal but this conspiracy is deeper than you think.Several new studies have come out exposing sunscreen and the poison in them. Big Pharma says it's not true and others claim the conspiracy is deeper than we all thought.  Let's look into the sunscreen paradox!Email us at: downtherh@protonmail.com

Did you know that your body already makes its own natural version of Ozempic?In this episode, you'll hear how GLP-1 works as a natural hormone, and why drugs like Ozempic and Wegovy exist: they copy the same hormone but are designed to last much longer.You'll hear how the GLP-1 that naturally disappears from your body in two minutes got turned into an appetite-reducing drug that lasts a full week.You'll also hear about what happens to people's weight after they stop taking GLP-1 drugs, as well as what leptin resistance actually is, and whether cutting sugar can reverse it better than GLP-1 drugs. Are GLP-1 drugs for you? Or does cutting sugar give the same result?And are you ready to go deeper and ask yourself why you turn to sugar to fill an emotional need?Only you have the answer! (But I will give you a few...)To get personalized guidance to stop emotional eating and break free from sugar cravings, plus support and accountability... join the 90-day program, Freedom from Cravings Formula TODAY.For step-by-step guidance toward freedom from cravings, get your copy of my new book: "Break Free from Sugar Cravings". Available on Amazon now!For free resources, Do the Cravings Quiz and take the first step to get rid of your cravings! Download your 5 tips HERE to discover how you can get rid of cravings... even when you feel tired or stressed.To rate and review this podcast:scroll down in your podcast player on your phone and click on the stars. To leave a review, scroll down a little more and click on "Write a Review". Once you've finished, select “Send” or “Save” in the top-right corner. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed on your review.After selecting a nickname, tap OK. Your review may not be immediately visible, but it should be posted soon. Thank you! - NettaDisclaimer: Information provided by Life After Sugar is not designed to and does not provide medical advice, professional diagnosis, opinion, treatment or services to you or to any other individual. This is general information for educational purposes only. The information provided ...

A 30-year law enforcement veteran shares the one piece of advice he gave a young academy classmate that stuck for an entire career: Don't hang out with the people you work with. In this powerful episode of Reasons We Serve, Jim Molesa (former Mesa PD, longtime DEA agent, and Navajo County Chief Deputy) opens up about mental health in public safety, the child abuse cases that burned him out, massive drug seizures, working with the FBI after 9/11, life on Indian reservations, and why law enforcement is finally confronting PTSD head-on. From patrol to elite federal work, Jim breaks down real wisdom on staying grounded, building healthy relationships, and surviving a career that exposes you to trauma multiple times a week. Key Timestamps: 00:02:56 - The advice that changed everything 00:10:14 - Child abuse cases that led to burnout 00:25:03 - 980-kilo cocaine bust as a new DEA agent 00:36:33 - Working 9/11 and Oklahoma City 00:44:05 - Life as DEA Public Information Officer 00:56:50 - Reopening the Flagstaff office & reservation work01:24:30 - PTSD in public safety: the crisis we must face If you respect the men and women who serve, hit LIKE, SUBSCRIBE, and turn on notifications. Drop a comment: What's the best career advice you ever received in uniform? For those interested in participating in the CLIPr program for first responders, please go here: https://clipr.ai/reasonsweserve Welcome to our channel, Reasons We Serve, a podcast dedicated to exploring the motivations, challenges, and realities of working in law enforcement. We dive deep into the personal stories of officers, discuss different career paths, and break down the roles of various agencies—from local police departments to state and federal law enforcement.

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I'm a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

April Flores and Rina Ellis join Ralph Sutton and Aaron Berg and they discuss Ralph's apartment leak, dad jokes prepared for a cancelled episode, April and Rina getting into the adult entertainment industry, April representing love of plus-sized women and more before they play SDR Scattergories - resulting in drinking, push-ups and boobies and finally we find out April and Rina's first concerts, first drugs and first sexual experiences!Air Date: 07/11/26To advertise your product or service on GaS Digital podcasts please go to TheADSide.com and click on "Advertisers" for more information!You can watch The SDR Show LIVE for FREE every Wednesday and Saturday at 9pm ET at GaSDigitalNetwork.com/LIVEOnce you're there you can sign up at GaSDigitalNetwork.com with promo code: SDR for discount on your subscription which will give you access to every SDR show ever recorded! On top of that you'll also have the same access to ALL the shows that GaS Digital Network has to offer!Follow the whole show on social media!April FloresInstagram: https://instagram.com/theaprilfloresRina EllisInstagram: https://instagram.com/rinaellisxAaron BergTwitter: https://twitter.com/aaronbergcomedyInstagram: https://instagram.com/aaronbergcomedyRalph SuttonTwitter: https://twitter.com/iamralphsuttonInstagram: https://www.instagram.com/iamralphsutton/Shannon LeeTwitter: https://twitter.com/IMShannonLeeInstagram: https://instagram.com/ShannonLee6982The SDR ShowTwitter: https://twitter.com/theSDRshowSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Seattle City Council is attempting to provide more clarity to laws on the books to crack down on drug crimes. 100 House Democrats back antisemitic bill by Thomas Massie. // LongForm: GUEST: Let's Go Washington's Brian Heywood reacts after Washington Democrats revealed what their line of attack against the income tax initiative is going to be. // Quick Hit: New documents reveal why Tim Walz pardoned an illegal immigrant child rapist.

Both Chris Stanley and Mike Finoia are back! This time Mike is the co-host and Chris is the guest because Bobby Kelly's flight was delayed. | Jay believes that every Rob Zombie song has the same exact formula and he still loves it. | Even though there is news about Ozempic causing blindness, Jay thinks it's a fair trade off. | Weight loss drug talk leads to a conversation about recreational drugs. Everyone in the room besides Big Jay has romantic memories of doing Molly and ecstasy. | Sometimes worms or rats are found in snacks. Mike Finoia can be found on SiriusXM's "Saturday Night Shakedown" and Chris Stanley can be heard on "The Bennington Show!" *To hear the full show to go www.siriusxm.com/bonfire to learn more! FOLLOW THE CREW ON SOCIAL MEDIA: @thebonfiresxm @louisjohnson @christinemevans @bigjayoakerson @robertkellylive @louwitzkee @jjbwolf Subscribe to SiriusXM Podcasts+ to listen to new episodes of The Bonfire ad-free and a whole week early.  Start a free trial now on Apple Podcasts or by visiting siriusxm.com/podcastsplus. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Lydia Wilts and Zac Amico join Ralph Sutton and Aaron Berg and they discuss clown culture, how clowns can turn from a fear into a fetish and more before they all compete to see who's the best clown by picking their clown names, doing their own make-up, miming different scenarios, using a clown horn to play a song, making balloon animals and so much more! We also hear Lydia's first concert, first drug and first sexual experience!Air Date: 07/08/26Support our sponsors!Mars Men - For a limited time, SDR Show fans get 50% off FOR LIFE, Free Shipping, & 3 Free Gifts at Mars Men at https://mengotomars.com/YoKratom.com - Check out Yo Kratom (the home of the $60 kilo) for all your kratom needs!To advertise your product or service on GaS Digital podcasts please go to TheADSide.com and click on "Advertisers" for more information!You can watch The SDR Show LIVE for FREE every Wednesday and Saturday at 9pm ET at GaSDigitalNetwork.com/LIVEOnce you're there you can sign up at GaSDigitalNetwork.com with promo code: SDR for discount on your subscription which will give you access to every SDR show ever recorded! On top of that you'll also have the same access to ALL the shows that GaS Digital Network has to offer!Follow the whole show on social media!Lydia WiltsInstagram: https://instagram.com/LydiaWiltsAaron BergTwitter: https://twitter.com/aaronbergcomedyInstagram: https://instagram.com/aaronbergcomedyRalph SuttonTwitter: https://twitter.com/iamralphsuttonInstagram: https://www.instagram.com/iamralphsutton/Shannon LeeTwitter: https://twitter.com/IMShannonLeeInstagram: https://instagram.com/ShannonLee6982The SDR ShowTwitter: https://twitter.com/theSDRshowSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Cheaper obesity medicines could unlock broader demand, while supply-chain bottlenecks and premium-drug innovation may also shape how the market evolves. Our analysts Terence Flynn and Thibault Boutherin break down the investor implications.Read more insights from Morgan Stanley.----- Transcript -----Terence Flynn: Welcome to Thoughts on the Market. I'm Terence Flynn, Morgan Stanley's U.S. Pharma and Biotech Analyst. Thibault Boutherin: And I'm Thibault Boutherin, Morgan Stanley's Europe Pharmaceuticals Analyst. Terence Flynn: Today, how cheaper GLP-1 obesity medicines could reshape access, pricing, and supply chains; and what the first generic markets may signal for Europe and the U.S. It's Monday, July 13th at 10am in New York. Thibault Boutherin: And it's 3 pm in London. Terence Flynn: Around one billion people live with obesity worldwide, including over a 100 million in the U.S. Right now, the introduction of the first lower cost generics of semaglutide, a GLP-1 medicine, in some international markets, could have consequences on affordability and demand. Thibault, what are the first countries seeing the introduction of sema generics? What are the current dynamics, and why should global investors pay attention? Thibault Boutherin: Sure. So, so far generics are being introduced this year in three countries: in India, Canada and Brazil. And if we look at India, this is the first market where the generics are being introduced. The patent for semaglutide expired in March 2026, and 13 companies have launched 26 generics across different formulations: autoinjectors, vials, and pills, which price is lower than the branded drug. And because the India market was quite under-penetrated for GLP-1, we are seeing affordability driving volume expansion. In Canada, two generics have been launched so far. Four other generics are waiting for approval, and more are being filed. And finally, in Brazil, one generic was approved last month, and we are expecting these generics to be launched in Brazil in July. And 17 other generics are in different stage of regulatory review in Brazil, and we would expect more to enter the market by the end of this year. And the reason why we focus on these markets is because we believe they could provide a blueprint for what could happen later in the U.S. and in Europe; in particular for Canada, which shares some characteristics with Europe and the U.S. And the patent for semaglutide will expire in Europe in 2031 and in the U.S. from 2032. Terence Flynn: Great. Maybe on the India front, I know that's at the leading edge. What happened with patient demand when price came down? Thibault Boutherin: Sure. So, what we saw in India is a surge in volume when generics were launched, and the volume in April 2026 were already six times higher than the volume in February. And that expansion has been driven mostly by these generics launch, which captured 80 percent of semaglutide volume in April. And our India team expect that the GLP-1 market in India will actually expand in value from $125 million in [20]25 to more than $1 billion by 2030, despite lower prices as we see better, you know, greater volume and greater adoption of GLP-1s in India. Terence Flynn: The other thing, you know, you and I have discussed is the supply chain, and one of the questions is the ability of some of the generic manufacturers to scale semaglutide. So, maybe talk to us about the current capabilities. And could we see bottlenecks in the supply chain formation here? Thibault Boutherin: Yeah, sure. So, there are three key elements to watch on the supply chain. The first is the active pharmaceutical ingredient or API, and that's the semaglutide molecule itself. The second element is the device and the device components, and the third element is the fill and finish, which is basically putting all of these things together. On the API side, so semaglutide molecule, we believe there will be no bottleneck in supplying for generics as we see a handful of large Chinese companies, out of China, building multi-ton capacity for semaglutide. So, we believe there will be no shortage of API to supply the generic supply chain for injectables. On the device, these are the same device companies that are supplying the branded version of semaglutide, and other GLP-1s for the device that are also supplying the generic makers. And we are seeing meaningful investments being made, so we don't believe there will be a bottleneck here. Where we could see a bottleneck emerging is on the fill and finish side. Fill and finish requires highly controlled clean room space to minimize contamination. It requires regulatory approval, and it takes up to three years to build fill and finish capacity. And so, that's where if there is not more investment being made over the next few years, there could potentially [be] a bottleneck emerging for the generic companies. Terence, while semaglutide generics will definitely represent a challenge for the existing branded version of this GLP-1, there are some insights in these emerging dynamics that suggest that tirzepatide, the other GLP-1, could be less at risk. Can you touch a bit on some of these dynamics? Terence Flynn: Absolutely. So, just to remind listeners that semaglutide targets a pathway called GLP-1. Tirzepatide actually targets two pathways. The first is GLP-1, and the second is GIP. And there are some data comparing these molecules, both in Type 2 diabetes and obesity. And tirzepatide gives not only better efficacy but also improved tolerability. And so, what you're seeing in some of the ex-U.S. markets is segmentation, where there are some consumers that are willing to pay a premium price for tirzepatide. Our team in Brazil has done a lot of work on this front looking at this dynamic and, you know, we expect that to play out in many geographies. So, despite the entry of lower-cost generic versions, we think you will still see segmentation of the market between differentiated brand and the lower-cost generics. And that as a result, you will continue to see branded growth.In the U.S. right now, market share is about 60 percent in favor of tirzepatide. And so again, you're seeing a differentiation between these two molecules. Thibault Boutherin: And beyond the introduction of generics GLP-1s, there are other dynamics in the industry that are driving this market. And the introduction of oral drugs this year has been a big topic. Terence, what are your views on the role that orals could play on the market? Terence Flynn: Yes, as a lot of people are probably aware, the many of the existing GLP-1 medicines are injectable. And so those are delivered once a week with a needle. But there are now additional oral options of these GLP-1 medicines. They started off first for Type 2 diabetes, but they have now broadened into obesity as well, following some recent FDA approvals. And what we're seeing is that the introduction in the U.S. so far is expanding the market. So, the majority of people that are taking the oral versions of these medicines are new users to GLP-1s. So again, you're getting market expansion. When you think about the orals as well, one of the other questions is capacity. I know, Thibault, you were talking about the supply chain. There are similar questions for these oral medicines because not all of the oral medicines are the same. Some are easier to manufacture than others, and as a result, that's another variable to consider. So, some of these are what's called peptide-based orals, and some of these are non-peptide-based orals. And the non-peptide-based orals are much easier to scale, for a larger global market. And so that's definitely another variable that we're monitoring and that I think investors need to consider. Thibault Boutherin: And beyond the pill versions of these GLP-1s, we are seeing more innovation in the drug pipeline of the industry, which could be a key driver of differentiation against the competition from the generics. So, what are we seeing emerging today from diabetes and obesity pipelines, which could be exciting for the future of the category? Terence Flynn: So, as we see time and time again in pharmaceutical markets, the key players continue to innovate to try to improve profiles of the existing medications. So, there are, you know, kind of two areas. One would be efficacy; another would be safety tolerability. And so, there are a number of players that are working first to develop longer acting medication. So, as I mentioned, the existing injectable drugs are dosed once weekly. But there are a number of companies that are working to develop potentially monthly or less frequent injections. So, that's one area that we're monitoring closely. And then the second, and again, this plays into what I discussed on tirzepatide, is additional pathways that are involved here in diabetes and obesity, and a number of players are working to target additional pathways beyond GLP-1 and GIP. And so, some of the leading pathways that are being studied are something called amylin and glucagon, and there are a number of medications that are in the late-stage pipeline that are coming along, which have some pretty interesting data. And so that's another area that we're watching. And again, the goal there would be to either improve efficacy and/or improve tolerability versus the existing medications. Thibault Boutherin: Great. And maybe we can also take this opportunity to talk about some of the short-term drivers in the market that are not facing generic today, like the U.S. So, what could be, you know, the key drivers for growth of GLP-1s and the overall obesity and diabetes category over the next five years? Terence Flynn: Yeah, obviously the key one is seeing additional uptake of these medicines. I think right now we estimate, again, obesity in particular, there's about low double-digit percent uptake. And so obviously seeing increasing uptake of these medicines. The orals, as I mentioned, are already driving market expansion. And then the third is access. So obviously in any market, that's very important. In the U.S., I think about 50 percent of employers cover these medications right now. We expect that to increase in the years ahead as the data continues to build. But then this year starting very shortly, the patients in the Medicare program in the U.S., so those people over the age of 65, will be able to access these medicines for $50 per month. And so, we think that is another driver of growth – is this will broaden access to about an additional 18 million people, starting this summer. So, the next phase of the diabesity market comes down to execution, lower cost and scaled supply in the mass market, and innovation and differentiation to compete in the premium segment. Thibault, thanks so much for taking the time to talk. Thibault Boutherin: Great speaking with you, Terence. Terence Flynn: And thanks for listening. If you enjoy Thoughts on the Market, please leave us a review wherever you listen and share the podcast with a friend or colleague today.